In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis
1998

VEGF and p53 in Oesophageal Cancer

Sample size: 109 publication Evidence: moderate

Author Information

Author(s): S Uchida, Y Shimada, G Watanabe, H Tanaka, I Shibagaki, T Miyahara, S Ishigami, S Arii, M Imamura

Primary Institution: Kyoto University

Hypothesis

Does vascular endothelial growth factor (VEGF) expression correlate with p53 mutation and affect prognosis in oesophageal squamous cell carcinoma?

Conclusion

VEGF expression is associated with p53 mutation, advanced cancer stage, and poorer prognosis in oesophageal squamous cell carcinoma.

Supporting Evidence

  • 59.6% of the tumors were classified as VEGF positive.
  • VEGF expression correlated significantly with the depth of invasion and lymph node metastasis.
  • Patients with VEGF-positive tumors had significantly worse prognoses than those with VEGF-negative tumors.

Takeaway

This study found that a protein called VEGF, which helps tumors grow blood vessels, is linked to a gene mutation and worse outcomes in patients with a type of throat cancer.

Methodology

The study examined 109 resected oesophageal squamous cell carcinomas for VEGF expression using immunohistochemical staining and analyzed correlations with p53 mutations and clinical factors.

Limitations

The study was limited to a specific patient population and may not generalize to all oesophageal cancer cases.

Participant Demographics

The participants included 88 males and 21 females, aged 43 to 84 years.

Statistical Information

P-Value

P = 0.0291

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication